Direkt zum Inhalt
Merck
  • Belgian case study on flumethrin residues in beeswax: Possible impact on honeybee and prediction of the maximum daily intake for consumers.

Belgian case study on flumethrin residues in beeswax: Possible impact on honeybee and prediction of the maximum daily intake for consumers.

The Science of the total environment (2019-08-16)
Noëmie El Agrebi, Olivier Wilmart, Bruno Urbain, Ellen L Danneels, Dirk C de Graaf, Claude Saegerman
ZUSAMMENFASSUNG

To assess the health risk posed by flumethrin residues in beeswax to honeybees and honey consumers, 124 wax samples randomly distributed in Belgium were analysed for flumethrin residues using liquid chromatography/tandem mass spectrometry. The risk posed by flumethrin residues in beeswax to honeybee health was assessed through the calculation of a non-pondered and a pondered Hazard Quotient by the prevalence rate of flumethrin considering an oral or topical exposure. No statistical difference was found when comparing both the average flumethrin residues concentrations and contact and oral pondered hazard quotients between apiaries with lower and equal or higher than 10% of colony loss. Flumethrin residues estimated daily intake by Belgian consumers through honey and wax ingestion was estimated via a deterministic (worst-case scenario) and a probabilistic approach. The probabilistic approach was not possible for beeswax consumption due to the lack of individual consumption data. The highest estimated exposure was <0.1% of the theoretical maximum daily intake for both approaches, meaning no risk for human health.